Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Assets Average: 2010-2025

Historic Assets Average for Aytu Biopharma (AYTU) over the last 16 years, with Jun 2025 value amounting to $121.1 million.

  • Aytu Biopharma's Assets Average rose 6.51% to $124.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.6 million, marking a year-over-year increase of 6.51%. This contributed to the annual value of $121.1 million for FY2025, which is 4.83% down from last year.
  • Per Aytu Biopharma's latest filing, its Assets Average stood at $121.1 million for FY2025, which was down 4.83% from $127.3 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Assets Average ranged from a high of $209.5 million in FY2021 and a low of $121.1 million during FY2025.
  • In the last 3 years, Aytu Biopharma's Assets Average had a median value of $127.3 million in 2024 and averaged $128.5 million.
  • As far as peak fluctuations go, Aytu Biopharma's Assets Average skyrocketed by 122.83% in 2021, and later plummeted by 32.04% in 2023.
  • Aytu Biopharma's Assets Average (MRY) stood at $209.5 million in 2021, then dropped by 3.74% to $201.6 million in 2022, then crashed by 32.04% to $137.0 million in 2023, then dropped by 7.12% to $127.3 million in 2024, then decreased by 4.83% to $121.1 million in 2025.
  • Its last three reported values are $121.1 million in FY2025, $127.3 million for FY2024, and $137.0 million during FY2023.